Article Details
Retrieved on: 2021-03-29 06:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Depending upon the class of drugs, the global market for oncology biosimilars can be divided into monoclonal antibody, G-CSF, and hematopoietic ...
Article found on: ksusentinel.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here